Combining SGLT2 inhibition with a thiazolidinedione additively attenuate the very early phase of diabetic nephropathy progression in type 2 diabetes mellitus
Eugene Han, Eugene Shin, Gyuri Kim, Ji Yeon Lee, Yong ho Lee, Byung Wan Lee, Eun Seok Kang, Bong Soo Cha
Fingerprint
Dive into the research topics of 'Combining SGLT2 inhibition with a thiazolidinedione additively attenuate the very early phase of diabetic nephropathy progression in type 2 diabetes mellitus'. Together they form a unique fingerprint.